Recruiting Depression Studies in Cerritos
Study to Assess the Safety and Effectiveness of NMRA-335140-501
This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who ...
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
This randomized, double-blind, placebo-controlled, multicenter study will evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Dis...
About Depression Clinical Trials in Cerritos
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Cerritos, CA. These studies are seeking a combined 1,332 participants. Research is being sponsored by Neumora Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Cerritos — FAQ
Are there depression clinical trials in Cerritos?
Yes, there are 2 depression clinical trials currently recruiting in Cerritos, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cerritos?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cerritos research site will contact you about next steps.
Are clinical trials in Cerritos free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cerritos studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Cerritos are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov